麻豆传媒

was associated with major cardiac events as much as -- and in some cases more than -- having a history of heart disease, U.K. Biobank data showed. (Arteriosclerosis, Thrombosis, and Vascular Biology)

An artificial intelligence (AI) model performed well in predicting . (European Heart Journal)

Several Medicare administrative contractors have agreed to cover AI-enabled quantitative coronary plaque analysis such as Cleerly's and Elucid's .

before cardiac surgery successfully reduced major adverse cardiovascular events 1 year after surgery. (Journal of the American College of Cardiology)

Higher BMI tracked with a higher risk of . (Journal of the American Heart Association)

ranked third for highest cardiovascular death rates in the U.S., behind Black and white adults. (Annals of Internal Medicine)

A Chinese group reported the first-in-human experience of , with the patient -- who had grade 4+ functional mitral regurgitation -- located thousands of miles away from the operator. (JACC: Cardiovascular Interventions)

In the phase III STEM-AMI OUTCOME trial, administering did not necessarily improve outcomes for people with left ventricular dysfunction after successful percutaneous coronary intervention for a large ST-elevation myocardial infarction. (Heart)

Abbott announced FDA clearance of the , for use during pulsed field ablation and radiofrequency ablation procedures.

Implantable cardioverter-defibrillators were no better than amiodarone for survival in , though they did reduce the risk of sudden cardiac death and heart failure in the CHAGASICS trial. (JAMA Cardiology)

A federal judge rejected Novartis' motion to declare as unlawful the FDA approval of a (Entresto) from MSN Laboratories.

For a minor nondisabling acute ischemic stroke, was tied to better prevention of early neurological deterioration with a better safety profile compared with IV alteplase. (Stroke)

Contego Medical announced FDA approval of the that combines a high-performance stent, an integrated dilation balloon, and integrated filter for embolic protection.

For selected children with large-vessel or medium-vessel occlusion strokes, compared favorably to medical treatment alone for improving functional outcomes, based on registry data. (Lancet Child & Adolescent Health)

Mendelian randomization analysis finds no causal relationship between . (European Journal of Preventive Cardiology)

Comment